Work on tomorrow’s innovations, today. Join us!

watch the video

We will find a solution for every heart disease.

We strongly believe in our mission at UMCG Cardiology. At this moment there are no cures for these conditions and this is unacceptable to us. We are looking for young and ambitious talents who share our ambition. Who want to make a difference with us. On this website you will find the projects we are currently working on, our people & teams, our latest news, our core believes and the wide range of vacancies.

Stay tuned automatically by subscribing to our newsletter at the bottom of the page.

Don’t miss out on our Spotlight

From groundbreaking discoveries and awards to new projects and key vacancies. The six most intriguing news items can be found here.

Check out the design paper of the DECISION trial

ERC Consolidator Grant for Peter van der Meer

New risk calculator for heart failure with type 2 diabetes

Heart Foundation grant for Michiel Rienstra

Hartfalenweek UMC Groningen

Work with us

Science is always a team effort and we are always looking for new talents to join our team. A wide range of vacancies are available at the UMCG Cardiology research center. A short description of the different positions can be found below. You need to have one thing in common with our team: you want to make a difference in the lives of people with heart disease. Now and in the future.

Scroll through the available vacancies below.

Students
PhD students
Physician-scientists
Postdocs

Discover our research

Where creative ideas and our cutting edge technology shape the treatments of tomorrow. Our research ranges from basic and translational science to multicenter clinical trials. Research at UMCG Cardiology is focused in four different areas. You can find our ongoing projects below and select the ones which interest you the most.

HF

Heart Failure

Heart Failure is a clinical syndrome with symptoms of dyspnea, fatigue and poor exercise capacity caused by structural or functional cardiac abnormalities. Patients with...

read more

PEXI-HF

Pancreatic Exocrine Insufficiency in Heart Failure

DECISION

Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands: DECISION

KETONE-HF

Harnessing the power of ketones

OUTREACH

SHE-PREDICTS HF

Predicting new-onset heart failure in women

BIOSTAT-CHF

Facilitate personalized therapies in patients with heart failure

Transthyretin amyloidosis cardiomyopathy

SECRETE-HF

Secreted factors in cardiac remodeling provoke tumorigenesis and end organ damage in heart failure

iPHORECAST

PHOspholamban RElated CArdiomyopathy STudy

Adiposity in Heart Failure with Preserved Ejection Fraction

Epicardial fat can cause heart failure with preserved ejection fraction.

RED-CVD

Improving early detection of CVD

MITO-FORCE

MITOchondrial therapy to increase cardiac FORCE and enhance exercise performance

Selenium and Heart Failure

Translational research focusing on synergy between lifestyle interventions and treating HF.

AF

Atrial Fibrillation

Our research is focused on risk identification and improvement of therapies for atrial fibrillation, with a specific interest for those with heart failure and preserved ejection fr ...

read more

EHRA-PATHS

EHRA-PATHS: Addressing multimorbidity in elderly atrial fibrillation patients through interdisciplinary, patient-centred, systematic care pathways.

RACE V

Reappraisal of Atrial Fibrillation: Interaction between hyperCoagulability, Electrical remodeling, and Vascular Destabilisation in the Progression of AF

RACE‐8‐HF

Comparing early ablation and standard therapy

RASTA AF

Reversal of Atrial Substrate to Prevent Atrial Fibrillation

RACE 9

Device-based rate versus rhythm control treatment in patients with symptomatic recent-onset atrial fibrillation in the emergency department

AF RISK

Identification of a risk profile to guide atrial fibrillation therapy

PROMINENT

Personalised Medicine in Chronic Disease Management

EC

Experimental Cardiology

Our main focus is pathological cardiac remodeling, which can culminate into heart failure, a condition that is associated with high morbidity and mortality. Amongst others we use.. ...

read more

KETONE-HF

Harnessing the power of ketones

STOP-HF

Stem cell models to unravel the susceptibility and resilience to develop heart failure

SECRETE-HF

Secreted factors in cardiac remodeling provoke tumorigenesis and end organ damage in heart failure

PLN cardiomyopathy

Investigating and treating phospholamban cardiomyopathy

MITO-FORCE

MITOchondrial therapy to increase cardiac FORCE and enhance exercise performance

Selenium and Heart Failure

Translational research focusing on synergy between lifestyle interventions and treating HF.

IHD

Ischemic Heart Diseases

Our work focuses on enhancing our understanding and improving the treatment of cardiovascular disease. To this end, we initiate clinical trials and perform in depth studies of big ...

read more

GIPS-IV trial

Preservation of myocardial function after myocardial infarction

Early Synergy

Early detection of obstructive coronary artery disease

REPLACE-IT

Cardiac CT and MR imaging to replace invasive coronary angiography in patients with suspicion of coronary artery disease (CAD)

Latest news

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Publication: DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters

Publication: Longitudinal changes in circulating ketone body levels in patients with acute heart failure: A post-hoc analysis of the EMPA-Response-AHF Trial

Belend Mahmoud receives award for best scientific presentation at Papendal 2022

Publication: Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction